Federica Biello

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients

Maria Giovanna Dal Bello, Rosangela Filiberti, Angela Alama et al. · Journal of Translational Medicine · 2019 · 203 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer

David J. Pinato, Alberto Zambelli, Mark Bower et al. · Cancer Discovery · 2020 · 183 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

David J. Pinato, Mark Bower, Lorenza Scotti et al. · The Lancet Oncology · 2021 · 136 citations · Full text

Medicine, Infectious Diseases, Oncology +6

Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer

Selene Ottonello, Carlo Genova, Vincenzo Fontana et al. · Frontiers in Immunology · 2020 · 109 citations · Full text

Life Sciences, Immunology, Oncology +17

Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients

Matteo Sarocchi, Francesco Grossi, Eleonora Arboscello et al. · The Oncologist · 2018 · 89 citations

Medicine, Cardiology, Oncology +16